Rodríguez López, Carmen María Author
Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: An uncontrolled, 12-week, pilot study
- Calandre E.
- Slim M.
- Garcia-Leiva J.
- Rodriguez-Lopez C.
- Torres P.
- Rico-Villademoros F.
PHARMACOPSYCHIATRY - 1/1/2014
- SJR Quartile: Q1
- JCR Impact Factor: 1.851 (2014)
- CiteScore: 7.1 (2020)
- SJR: 0.906 (2014
- SNIP: 1.152 (2014
- JCR 5-year Impact Factor: 2.171
- JCR Categories: PSYCHIATRY
- SJR Categories: Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)
- Scopus
- ORCID
- Web of Science
Amisulpride in the treatment of fibromyalgia: an uncontrolled study.
- Rico-Villademoros F.
- Rodriguez-Lopez C.
- Morillas-Arques P.
- Vilchez J.
- Hidalgo J.
- Calandre E.
Clinical rheumatology - 1/09/2012
- SJR Quartile: Q2
- JCR Impact Factor: 2.037 (2012)
- CiteScore: 4.5 (2020)
- SJR: 0.817 (2012
- SNIP: 1.1 (2012
- JCR 5-year Impact Factor: 1.866
- JCR Categories: RHEUMATOLOGY
- SJR Categories: Medicine (miscellaneous) (Q2); Rheumatology (Q2)
- Scopus
- ORCID
- Web of Science
Dimensionality, reliability, and validity of the revised fibromyalgia impact questionnaire in two spanish samples
- Luciano J.
- Aguado J.
- Serrano-Blanco A.
- Calandre E.
- Rodriguez-Lopez C.
ARTHRITIS CARE and RESEARCH - 1/10/2013
- SJR Quartile: Q1
- JCR Impact Factor: 4.039 (2013)
- CiteScore: 8.2 (2020)
- SJR: 2.501 (2013
- SNIP: 1.921 (2013
- JCR 5-year Impact Factor: 4.753
- JCR Categories: RHEUMATOLOGY
- SJR Categories: Rheumatology (Q1)
- Scopus
- ORCID
- Web of Science
[Lipid peroxidation in adult epileptic patients treated with valproic acid]
- Martínez-Ballesteros C
- Pita-Calandre E
- Sánchez-González Y
- Rodríguez-López CM
- Agil A
Revista de neurologia - 16/1/2004
- JCR Quartile: Q4 (2004)
- SJR Quartile: Q3
- JCR Impact Factor: 0.21 (2022)
- Category normalized Impact: 0.475 (2004)
- CiteScore: 1.4 (2020)
- SJR: 0.199 (2004
- SNIP: 0.311 (2004
- SJR Categories: Medicine (miscellaneous) (Q3); Neurology (clinical) (Q3)
- Scopus
- ORCID
- Web of Science
Monotherapy or combination therapy for fibromyalgia treatment
- Calandre E.
- Rico-Villademoros F.
- Rodríguez-López C.
Current Rheumatology Reports - 1/12/2012
- SJR Quartile: Q1
- JCR Impact Factor: 3.873 (2022)
- Category normalized Impact: 0.453 (2012)
- CiteScore: 6.6 (2020)
- SJR: 1.124 (2012
- SNIP: 1.104 (2012
- SJR Categories: Rheumatology (Q1)
- Scopus
- ORCID
- Web of Science
Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: An open-label pilot study
- Hidalgo-Tallón J.
- Menéndez-Cepero S.
- Vilchez J.
- Rodríguez-López C.
- Calandre E.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE - 1/3/2013
- JCR Quartile: Q2 (2013)
- SJR Quartile: Q1
- JCR Impact Factor: 1.518 (2013)
- Category normalized Impact: 0.615 (2013)
- CiteScore: 3.5 (2020)
- SJR: 0.519 (2013
- SNIP: 1.057 (2013
- JCR 5-year Impact Factor: 1.985
- JCR Categories: INTEGRATIVE & COMPLEMENTARY MEDICINE
- SJR Categories: Complementary and Alternative Medicine (Q1)
- Scopus
- ORCID
- Web of Science
Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial.
- Calandre E.
- Morillas-Arques P.
- Rodriguez-Lopez C.
- Rico-Villademoros F.
- Hidalgo J.
Pharmacopsychiatry - 1/03/2007
- SJR Quartile: Q1
- CiteScore: 7.1 (2020)
- SJR: 1.093 (2007
- SNIP: 1.015 (2007
- SJR Categories: Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)
- Scopus
- ORCID
- Web of Science
Pregabalin in the treatment of chronic migraine: An open-label study
- Calandre E.
- Garcia-Leiva J.
- Rico-Villademoros F.
- Vilchez J.
- Rodriguez-Lopez C.
CLINICAL NEUROPHARMACOLOGY - 1/1/2010
- SJR Quartile: Q2
- JCR Impact Factor: 1.578 (2010)
- CiteScore: 2.6 (2020)
- SJR: 0.634 (2010
- SNIP: 0.673 (2010
- JCR 5-year Impact Factor: 2.065
- JCR Categories: CLINICAL NEUROLOGY
- SJR Categories: Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)
- Scopus
- ORCID
- Web of Science
Quality of life in perimenopausal women working in the health and educational system
- Membrive J.
- Granero-Molina J.
- Salmerón M.
- Fernández-Sola C.
- López C.
- Carreñeo T.
Revista Latino-Americana de Enfermagem - 1/11/2011
10.1590/s0104-11692011000600006
- JCR Quartile: Q4 (2011)
- SJR Quartile: Q1
- JCR Impact Factor: 0.625 (2011)
- Category normalized Impact: 0.466 (2011)
- CiteScore: 1.9 (2020)
- SJR: 0.502 (2011
- SNIP: 0.963 (2011
- JCR Categories: NURSING
- SJR Categories: Nursing (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
Quetiapine extended-release (Seroquel-XR) versus amitriptyline monotherapy for treating patients with fibromyalgia: A 16-week, randomized, flexible-dose, open-label trial
- Calandre E.
- Rico-Villademoros F.
- Galán J.
- Molina-Barea R.
- Vilchez J.
- Rodriguez-Lopez C.
- Hidalgo-Tallon J.
- Morillas-Arques P.
PSYCHOPHARMACOLOGY - 1/1/2014
- SJR Quartile: Q1
- JCR Impact Factor: 3.875 (2014)
- CiteScore: 6 (2020)
- SJR: 1.955 (2014
- SNIP: 1.109 (2014
- JCR 5-year Impact Factor: 3.974
- JCR Categories: PSYCHIATRY
- SJR Categories: Pharmacology (Q1)
- Scopus
- ORCID
- Web of Science
This author has no conferences.
This author has no patents.
Pregabalin effectiveness and tolerability in the prophylactic treatment of chronic migraine (2007) 27(10) 1179 (10.1111/j.1468-2982.2007.01481.x)
- Calandre E.
- Garcia-Leiva J.
- Rodriguez-Lopez C.
- Rico-Villademoros F.
Cephalalgia - 1/1/2007
10.1111/j.1468-2982.2007.01481.x
- SJR Quartile: Q1
- CiteScore: 8.1 (2020)
- SJR: 1.143 (2007
- SNIP: 1.211 (2007
- SJR Categories: Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1)
h index
Scopus: 13
Web of Science: 14
i10 index
Scopus: 13
Web of Science: 17
Author profiles
-
ORCID
-
Scopus Author ID
Research projects at UAL
- This author has no currently assigned projects.